Saudi Arabia Flu Diagnostic And Treatment Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027

The Saudi Arabia flu diagnostic and treatment market is projected to grow at a CAGR of 12.43% throughout the forecast period. The market was valued at US$260.693 million in the year 2020 and is projected to attain a value of US$592.111 million by 2027. The market in Saudi Arabia is poised to surge at a decent CAGR owing to the fact that the country is one of the most prominent countries in the Middle East and African region regarding healthcare. The country spends a significant amount of GDP on healthcare for both services and infrastructure. The healthcare expenditure of the country has been increasing significantly since 2010 which is one of the key factors supporting the market growth in Saudi Arabia during the forecast period. The increasing government spending on healthcare and social development is also anticipated to propel the market growth opportunities for the flu diagnostic and treatment market to surge in Saudi Arabia throughout the forecast period and beyond. This rapid increase in the healthcare sector, combined with rising healthcare awareness among people, will result in a rise in the demand for various treatments and healthcare services in the country during the forecast period. All these factors collectively contribute to the market growth of the Saudi Arabia flu diagnostic and treatment market during the coming years.

Additionally, the continuous evolution of the healthcare sector in the country as the growing focus of the government towards the privatization of healthcare due to economic diversification and reducing its dependence on the public sector is also anticipated to propel the market growth opportunities during the coming years. Furthermore, the seasonal prevalence of seasonal flu in the country along with the presence of the state-of-the-art healthcare sector of the country is also projected to positively impact the market growth during the next five years.

The Saudi Arabia flu diagnostic and treatment market has been segmented on the basis of the type of flu, offering, age group, and end-user. On the basis of the type of flu, the market has been classified into type A and type B. Type the flu is anticipated to hold a significant market share as type A is considered to be one of the most common types of flu diagnosed throughout the country. By offering, the market has been segmented into diagnostics and therapeutics. The market has been divided into three age groups: 0-14 years, 15-64 years, and >=65 years. By the end-user, the segmentation has been done on the basis of a hospital laboratory, outpatient clinic, and reference laboratory. The hospital laboratory segment is projected to show decent growth on account of the rising number of patient admissions in hospitals due to seasonal flu outbreaks in the country.

Key Developments in the Market

• In November 2021, The Ministry of Health in Saudi Arabia commenced a public awareness campaign to encourage flu shots among individuals who are most susceptible to seasonal flu. The Ministry of Health in Saudi Arabia has begun a public awareness campaign to encourage flu shots among individuals who are most susceptible to seasonal flu. The campaign aims to lower the rate of infection and the number of seasonal influenza-related hospital admissions while also increasing the number of patients who receive vaccinations through health centres.
• In April 2022, the World Health Organization commenced the pilot testing of EMFLU-2, its updated influenza platform, in Saudi Arabia. The newly upgraded platform can gather more data gathering and perform much more optimized analysis, including the ability to collect and share multi-pathogen laboratory data. The key to minimizing the effects of influenza epidemics is early detection and response, and increasing the availability of high-quality surveillance data is one method to do this. The objective of this platform is to enable fast data collection and analysis to aid policy-makers in putting effective and timely preparedness and response measures into place. 

COVID-19 Insights:

COVID-19 had a positive impact on the Saudi Arabia Flu and diagnostic market. Since COVID-19 and influenza have many of the same symptoms, there has been an increase in the use of influenza diagnostic kits to precisely identify the infection's origin. Additionally, the increased government initiatives to thwart the seasonal flu from spreading sparked a rise in market demand during the epidemic.

Saudi Arabia Flu Diagnostic and Treatment Market Scope:

 

Report Metric	Details
Market Size Value in 2020	US$260.693 million
Market Size Value in 2027	US$592.111 million
Growth Rate	CAGR of 12.43% from 2020 to 2027
Base Year	2020
Forecast Period	2022–2027
Forecast Unit (Value)	USD Million
Segments Covered	Type of Flu, Offering, Age Group, And End-User
Companies Covered	F. Hoffmann-La Roche Ltd, SA Scientific, 3M, Meridian Bioscience
Customization Scope	Free report customization with purchase

 

Key Market Segmentation

• By Type of Flu
  • Type A
  • Type B
• By Offering
  • Diagnostics
    • Rapid Influenza Diagnostic Test
    • Rapid Molecular Assay
    • Others
  • Therapeutics
• By Age Group
  • 0-14 Years
  • 15-64 Years
  • >=65 Years
• By End-User
  • Hospital Laboratory
  • Outpatient Clinic
  • Reference Laboratory

---